295 related articles for article (PubMed ID: 3071344)
21. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia.
Wright DG; LaRussa VF; Salvado AJ; Knight RD
J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515
[TBL] [Abstract][Full Text] [Related]
22. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures.
Vellenga E; Ostapovicz D; O'Rourke B; Griffin JD
Leukemia; 1987 Aug; 1(8):584-9. PubMed ID: 2444835
[TBL] [Abstract][Full Text] [Related]
23. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
[TBL] [Abstract][Full Text] [Related]
24. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
[TBL] [Abstract][Full Text] [Related]
25. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
Karp JE; Burke PJ; Donehower RC
Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
[TBL] [Abstract][Full Text] [Related]
26. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
[TBL] [Abstract][Full Text] [Related]
27. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
Wörmann B; Reuter C; Zühlsdorf M; Büchner T; Hiddemann W
Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145
[TBL] [Abstract][Full Text] [Related]
28. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
Richman CM; Slapak CA; Toh B
J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
[TBL] [Abstract][Full Text] [Related]
29. Response of leukemic cells to the sequential combination of GM-CSF and G-CSF.
Inoue C; Murate T; Hotta T; Saito H
Int J Cell Cloning; 1990 Jan; 8(1):54-62. PubMed ID: 1688453
[TBL] [Abstract][Full Text] [Related]
30. Growth response of human myeloid leukemia cells to colony-stimulating factors.
Pébusque MJ; Lopez M; Torres H; Carotti A; Guilbert L; Mannoni P
Exp Hematol; 1988 Jun; 16(5):360-6. PubMed ID: 2453372
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
33. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
[TBL] [Abstract][Full Text] [Related]
34. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Estrov Z; Freedman MH
Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
[TBL] [Abstract][Full Text] [Related]
35. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
[TBL] [Abstract][Full Text] [Related]
37. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
Yang GS; Minden MD; McCulloch EA
Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
[TBL] [Abstract][Full Text] [Related]
38. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
[TBL] [Abstract][Full Text] [Related]
39. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
40. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
He Q; Xu YH
Yao Xue Xue Bao; 1996; 31(5):340-5. PubMed ID: 9275711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
